Dafda A, Singh NR, Chhabra A. Effectiveness and safety of daily versus alternate-day rosuvastatin dose in dyslipidemic patients: a prospective, randomized and open-label study. Int J Basic Clin Pharmacol [Internet]. 2024 Dec. 24 [cited 2025 Oct. 23];14(1):50-4. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/5761